Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2012 by BioMimetic Therapeutics
Sponsor:
Information provided by (Responsible Party):
BioMimetic Therapeutics
ClinicalTrials.gov Identifier:
NCT01746420
First received: December 7, 2012
Last updated: December 10, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)